Average Co-Inventor Count = 5.85
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (21 from 2,405 patents)
2. Merck + Co., Inc. (8 from 4,770 patents)
3. Other (4 from 832,680 patents)
4. Msd R&d (china) Co., Ltd. (1 from 10 patents)
5. Merck Sharp & Dhome Corp. (1 from 1 patent)
6. Msd R&d Co., Ltd. (0 patent)
34 patents:
1. 10934312 - Tricyclic heterocycle compounds useful as HIV integrase inhibitors
2. 10786488 - Substituted quinolizine derivatives useful as HIV integrase inhibitors
3. 10624912 - Spirocyclic Pyridotriazine Derivatives useful as HIV integrase inhibitors
4. 10548910 - Amido-substituted pyridotriazine derivatives useful as HIV integrase inhibitors
5. 10544155 - Spirocyclic quinolizine derivatives useful as HIV integrase inhibitors
6. 10233193 - Fused tricyclic heterocyclic compounds useful for treating HIV infection
7. 10221186 - Spirocyclic heterocyclic compounds useful as HIV integrase inhibitors
8. 10201533 - Substituted quinolizine derivatives useful as HIV integrase inhibitors
9. 10150780 - Spirocyclic heterocycle compounds useful as HIV integrase inhibitors
10. 10138255 - Piperazine derivatives as HIV protease inhibitors
11. 10081647 - Phosphate substituted quinolizine derivatives useful as HIV integrase inhibitors
12. 9861620 - Substituted quinolizine derivatives useful as HIV integrase inhibitors
13. 9840478 - Piperazine derivatives as HIV protease inhibitors
14. 9714243 - 4-pyridinonetriazine derivatives as HIV integrase inhibitors
15. 9707234 - Spirocyclic hetercycle compounds useful as HIV integrase inhibitors